Thu, Jan 29, 2015, 7:21 AM EST - U.S. Markets open in 2 hrs 9 mins


% | $
Quotes you view appear here for quick access.

Cellceutix Corporation Message Board

  • biomgr11 biomgr11 Dec 28, 2012 9:33 AM Flag

    Dana-Farber to administer Cellceutix anti cancer drug

    US based adult and pediatric cancer treatment and research institute, Dana-Farber Cancer Institute will administer Cellceutix Kevetrin to patients as part of the commenced clinical trials of the drug.

    Cellceutix chief scientific officer Krishna Menon said to date, everything is completed and Cellceutix is waiting for the host hospitals to begin dosing patients, which the company anticipates will happen shortly, but it is in the hospitals' hands at the point.

    "Dana-Farber is one of the few hospitals in the world that collects data 'mapping' the human genome as related to tumor profiling and the information that will be collected from our clinical trials of Kevetrin™ could prove an invaluable asset to those suffering from cancer and to Cellceutix," Menon added.

    Kevetrin is an anti cancer drug that uses both wild and mutant types of p53,which is produced by Cellceutix.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.53-0.10(-2.75%)Jan 28 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Nokia Corporation
NYSEWed, Jan 28, 2015 4:01 PM EST